Back to Directory
Exenatide Extended-Release
Metabolic & Weight ManagementOnce-weekly formulation of exenatide for improved convenience in diabetes management.
Key Benefits
- ✓Improved glycemic control
- ✓Weight loss
- ✓Once-weekly convenience
- ✓Reduces A1C
- ✓Better compliance than daily
Dosing Information
Dosage Range
2 mg
Frequency
Once weekly
Typical Duration
Ongoing
Detailed Protocol
Administered via subcutaneous injection once weekly, any day, any time, with or without food. Available as pen or single-dose tray. Prescription required.
About Exenatide Extended-Release
Exenatide extended-release (Bydureon) is a microsphere formulation of exenatide that allows once-weekly dosing. Same GLP-1 receptor agonist as Byetta but with sustained release technology providing constant therapeutic levels.
Research Notes
FDA-approved in 2012. Studies show similar efficacy to daily exenatide with improved convenience. Microsphere technology allows once-weekly dosing.
Potential Side Effects
- •Injection site nodules (common)
- •Nausea
- •Diarrhea
- •Headache
- •Vomiting
Always consult with a healthcare professional before starting any peptide therapy.